Validation of a high throughput fluorescent Capillary Electrophoresis Sodium Dodecyl Sulfate method for monoclonal antibody size heterogeneity assessment

Fluorescent capillary gel electrophoresis (CGE) with sodium dodecyl sulfate (CE SDS) provides a powerful, high sensitivity alternative to ultraviolet (UV) based detection for characterizing therapeutic monoclonal antibodies (mAb). Regulatory and standards organizations, such as the United States Pharmacopeia (USP), include only UV based CE-SDS methods, hindering adoption of alternative detection methods. There is growing opportunity to expand beyond exclusively UV based CE SDS methods. In this study, we present an analytical validation of a light-emitting diode (LED) fluorescence-based parallel CE SDS method for both non reduced and reduced analysis of therapeutic antibodies. Using the NISTmAb reference material as a model system, size heterogeneity critical quality attributes (CQAs) including monomeric purity (non-reduced conditions), percent glycosylation (reduced conditions), and percent thioether (reduced conditions) were assessed. The fluorescence method demonstrated high specificity and precision with relative standard deviation (RSD) values 0.99 for both non reduced and reduced analyses. These results highlight the high sensitivity, stable baseline performance, and suitability of LED fluorescence-based parallel CE SDS as a validated, higher throughput alternative to traditional UV based methods for mAb quality control (QC).